Recent News

Immunotherapy Might Not Be a Good Option for Mesothelioma

June 20, 2025

Mesothelioma is a rare and aggressive cancer mainly caused by asbestos exposure that creates challenges for patients and caregivers. Immune checkpoint inhibitors have brought hope to patients, but new data[…]

Read More

Multimodal Therapy to Treat Pleural Mesothelioma

June 13, 2025

Malignant pleural mesothelioma is a deadly cancer that is mainly caused by asbestos exposure. It affects the lungs’ lining. It is a very hard to treat cancer because it is[…]

Read More

Gene Expression’s Relationship with Pleural Mesothelioma

June 6, 2025

Alterations in DNA of patients exposed to asbestos can lead to gene expression, which explains the development of malignant pleural mesothelioma, a rare and aggressive cancer. Scientists were able to[…]

Read More

CRS and HIPEC for Peritoneal Mesothelioma

May 30, 2025

Peritoneal mesothelioma is a rare and aggressive cancer linked to asbestos exposure. A promising option for treating the cancer includes cytoreductive surgery (CRS) with heated chemotherapy (HIPEC). A new article[…]

Read More

Analysis of 70 Mesothelioma Cases

May 23, 2025

Malignant pleural mesothelioma is a severe cancer mainly caused by asbestos exposure. It often appears decades after exposure. Early on, symptoms can be unclear, making it difficult to diagnose. Even[…]

Read More

PORT-7 for the Treatment of Mesothelioma

May 16, 2025

Results from a clinical trial being performed on malignant pleural mesothelioma patients will be presented at the American Association for Cancer Research meeting being held in Chicago, Illinois. Results will[…]

Read More

Ageing and Mesothelioma

May 9, 2025

Mesothelioma, a rare and aggressive cancer mainly caused by asbestos exposure, mostly affects the lining of the lungs, but can also affect the lining of the abdomen, heart, and testicles.[…]

Read More

Immunotherapy to Treat Pleural Mesothelioma

April 25, 2025

Malignant pleural mesothelioma is a rare and very aggressive cancer with a poor outlook. One cancer treatment has brought hope though. The treatment is known as immune checkpoint inhibitors. There[…]

Read More

Johnson & Johnson’s Talc Settlement Proposal Denied

April 18, 2025

A United States Bankruptcy Judge from the Southern District of Texas has denied Johnson & Johnson’s $10 billion baby powder settlement proposal. This is the third time J&J has tried[…]

Read More

Asbestos Delays Wildfire Cleanup

April 11, 2025

Asbestos testing with certified asbestos consultants and other experts has been ongoing since two wildfires, Eaton and Palisades, blazed across California in 2025. More properties that were burned in the[…]

Read More